Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-03T05:14:27.310Z Has data issue: false hasContentIssue false

32 - Biological Events

from Subpart IIIA: - CBRNE and HAZMAT

Published online by Cambridge University Press:  05 April 2016

By
Zygmunt F. Dembek  and
Theodore J. Cieslak
Edited by
Kristi L. Koenig  and
Carl H. Schultz
Kristi L. Koenig
Affiliation:
University of California, Irvine
Carl H. Schultz
Affiliation:
University of California, Irvine
Get access
Type
Chapter
Information
Koenig and Schultz's Disaster Medicine
Comprehensive Principles and Practices
 , pp. 522 - 543
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Derbes, VJ. De Mussis and the great plague of 1348. A forgotten episode of bacteriological warfare. JAMA April 4, 1966; 196(1): 59–62.CrossRefGoogle ScholarPubMed
Parkman, F. The Conspiracy of Pontiac and the Indian War after the Conquest of Canada. vol. 2. Boston MA, Little, Brown, and Co, 1901.Google Scholar
Koenig, R. The Fourth Horseman: One man's secret campaign to fight the Great War in America. New York: Public Affairs, 2006.Google Scholar
Hugh-Jones, M. Wickham Steed and German biological warfare research. Intell Natl Secur 1992; 7: 379–402.Google Scholar
Harris, S. Japanese biological warfare research on humans: a case study of microbiology and ethics. Ann N Y Acad Sci December 31, 1992; 666: 21–52.CrossRefGoogle ScholarPubMed
Christopher, GW, Cieslak, TJ, Pavlin, JA, Eitzen EM, Jr. Biological warfare. A historical perspective. JAMA August 6, 1997; 278(5): 412–417.CrossRefGoogle ScholarPubMed
Carus, W. Bioterrorism and biocrimes: the illicit use of biological agents in the 20th century. Washington, DC, National Defense University, 1999.Google Scholar
Protocol for the Prohibition of the Use in War of Asphyxiat-ing, Poisonous or Other Gases, and of Bacteriological Methods of Warfare. Signed at Geneva June 17, 1925. http://www.un.org/disarmament/WMD/Bio/pdf/Status_Protocol.pdf (Accessed August 27, 2015).Google Scholar
Sims, N. The diplomacy of biological disarmament. vol. 18. New York, St Martin's Press, 1988.Google Scholar
UDot, Army. US Army activity in the US biological warfare programs. Washington, DC, U.S. Dept of the Army, February 24, 1977; 2.Google Scholar
Vorobjev, A, Cherkassky, B, Stepanov, A, Kyuregyan, Y, Fjedorov, M. Key problems of controlling especially dangerous infections. Paper presented at: Proceedings of an International Symposium: Severe infection diseases: epidemiology, express-diagnostics and prevention. Kirov, Russia, 1997.Google Scholar
Alibek, K, Handelman, S. Biohazard : the chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it. 1st ed. New York, Random House, 1999.Google Scholar
Torok, TJ, Tauxe, RV, Wise, RP, et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA August 6, 1997; 278(5): 389–395.CrossRefGoogle ScholarPubMed
Kolavic, SA, Kimura, A, Simons, SL, Slutsker, L, Barth, S, Haley, CE. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination. JAMA August 6, 1997; 278(5): 396–398.CrossRefGoogle ScholarPubMed
Jernigan, DB, Raghunathan, PL, Bell, BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis October 2002; 8(10): 1019–1028.CrossRefGoogle Scholar
7 CFR Part 331, 9 CFR Part 121, 42 CFR Part 73.Google Scholar
Atlas, R. Biological weapons pose challenge for microbiology community. ASM News 1998; 64: 383–389.Google Scholar
NATO Handbook on the Medical Aspects of NBC Defensive Operations (AmedP-6) Departments of the Army, Navy, and Air Force, February 1996. http://fas.org/irp/doddir/army/fm8-9.pdfGoogle Scholar
Joshi, D, Kumar, D, Maini, AK, Sharma, RC. Detection of biological warfare agents using ultra violet-laser induced fluorescence LIDAR. Spectrochim Acta A Mol Biomol Spectrosc August 2013; 112: 446–456.CrossRefGoogle Scholar
Bioterrorism alleging use of anthrax and interim guidelines for management – United States, 1998. MMWR, February 5, 1999; 48(4): 69–92.Google Scholar
Health aspects of chemical and biological weapons. Geneva, World Health Organization, 1970.Google Scholar
Rotz, LD, Khan, AS, Lillibridge, SR, Ostroff, SM, Hughes, JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis February 2002; 8(2): 225–230.CrossRefGoogle ScholarPubMed
CDC. Inhalation anthrax associated with dried animal hides – Pennsylvania and New York City, 2006. MMWR 2006; 55(10): 280–282.Google Scholar
CDC. Cutaneous anthrax associated with drum making using goat hides from West Africa – Connecticut, 2007. MMWR 2008; 57(23): 628–631.Google Scholar
Jernigan, JA, Stephens, DS, Ashford, DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis November–December 2001; 7(6): 933–944.CrossRefGoogle ScholarPubMed
Sprenkle, MD, Griffith, J, Marinelli, W, Boyer, AE, Quinn CP, Pesik NT, et al. Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA. Emerg Infect Dis February 2014. http://dx.doi.org/10.3201/eid2002.130245 (Accessed March 13, 2014).CrossRefGoogle Scholar
Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis. MMWR Morb Mortal Wkly Rep 2001; 50(43): 960.Google Scholar
CDC. Use of vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 2010; 59(RR-6): 1–30.Google Scholar
CDC. Use of vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 2010; 59(RR-6): 1–30.Google Scholar
Stern, EJ, Uhde, KB, Shadomy, SV, Messonnier, N. Conference report on public health and clinical guidelines for anthrax [conference summary]. Emerg Infect Dis April 2008. http://wwwnc.cdc.gov/eid/article/14/4/07–0969.htm (Accessed September 9, 2013).CrossRefGoogle ScholarPubMed
Inglesby, TV, O'Toole, T, Henderson, DA, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA May 1, 2002; 287(17): 2236–2252.CrossRefGoogle ScholarPubMed
Department of Health and Human Services. Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order. Federal Register 2005; 70(242): 75180–75198.Google Scholar
BiothraxTM (Anthrax Vaccine Absorbed). Prescribing information. Emergent Biosolutions, Rockville, MD. Revised May 2012. http://www.biothrax.com/prescribinginformation_biothrax_us.pdf (Accessed August 27, 2015).Google Scholar
Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2002; 51(45): 1024–1026.Google Scholar
Fenner, FHD, Arita, I, Jezek, Z, Ladnyi, ID. Smallpox and its eradication. Geneva, World Health Organization, 1988.Google Scholar
Henderson, DA, Inglesby, TV, Bartlett, JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA June 9, 1999; 281(22): 2127–2137.CrossRefGoogle Scholar
Smith, JA, Casey, CG, Tierney, BC. The ocular complications of smallpox and smallpox immunization. Arch Ophthalmol September 2004; 122(9): 1407; author reply 1407–1408.CrossRefGoogle ScholarPubMed
Eeckels, R, Vincent, J, Seynhaeve, V. Bone Lesions Due to Smallpox. Arch Dis Child December 1964; 39: 591–597.CrossRefGoogle ScholarPubMed
Wehrle, PF, Posch, J, Richter, KH, Henderson, DA. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull World Health Organ 1970; 43(5): 669–679.Google Scholar
Jezek, Z, Szczeniowski, M, Paluku, KM, Mutombo, M. Human monkeypox: clinical features of 282 patients. J Infect Dis August 1987; 156(2): 293–298.CrossRefGoogle ScholarPubMed
Update: multistate outbreak of monkeypox – Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep July 11, 2003; 52(27): 642–646.Google Scholar
http://www.cdc.gov/ncidod/monkeypox/vaccineqa.htm (Accessed August 27, 2015).Google Scholar
Buller, RM, Owens, G, Schriewer, J, Melman, L, Beadle, JR, Hostetler, KY. Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model. Virology January 20, 2004; 318(2): 474–481.CrossRefGoogle Scholar
Acute, Generalized Vesicular or Pustular Rash Illness Testing Protocol in the United States. Centers for Disease Control and Prevention, Atlanta, GA, 2006. http://www.bt.cdc.gov/agent/smallpox/diagnosis/rashtestingprotocol-chart2.asp (Accessed August 27, 2015).Google Scholar
Beachkofsky, TM, Carrizales, SC, Bidinger, JJ, Hrncir, DD, Whitemore, DE, Hivnor, CM. Adverse events following smallpox vaccination with ACAM2000 in a military population. Arch Dermatol 2010; 146(6): 656–661.CrossRefGoogle Scholar
Smallpox Vaccine. Dried, Calf Lymph Type. Dryvax. Dried Smallpox Vaccine. Package Insert. Philadelphia, Wyeth Pharmaceuticals, Inc., June 2007.Google Scholar
Casey, CG, Iskander, JK, Roper, MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA December 7, 2005; 294(21): 2734–2743.CrossRefGoogle ScholarPubMed
Smallpox vaccination and adverse reactions: guidance for clinicians. Ann Pharmacother March 2003; 37(3): 467–468.CrossRefGoogle Scholar
Grabenstein, JD, Winkenwerder, W. US military smallpox vaccination program experience. JAMA June 25, 2003; 289(24): 3278–3282.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. JAMA April 23–30, 2003; 289(16): 2064.CrossRefGoogle Scholar
Parrino, J, Graham, BS. Smallpox vaccines: Past, present, and future. J Allergy Clin Immunol December 2006; 118(6): 1320–1326.CrossRefGoogle ScholarPubMed
Wittek, R. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. Int J Infect Dis May 2006; 10(3): 193–201.CrossRefGoogle ScholarPubMed
Inglesby, TV, Dennis, DT, Henderson, DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA May 3, 2000; 283(17): 2281–2290.Google ScholarPubMed
Dembek, ZF, et al., eds. Medical Management of Biological Casualties Handbook. The USAMRIID “Blue Book.” 7th ed. Fort Detrick, MD, USAMRIID, September 2011.Google Scholar
Perry, RD, Fetherston, JD. Yersinia pestis–etiologic agent of plague. Clin Microbiol Rev January 1997; 10(1): 35–66.CrossRefGoogle ScholarPubMed
Sonnabend, O, Sonnabend, W, Heinzle, R, Sigrist, T, Dirnhofer, R, Krech, U. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis January 1981; 143(1): 22–27.CrossRefGoogle ScholarPubMed
Barash, JR, Tang, TW, Arnon, SS. First case of infant botulism caused by Clostridium baratii type F in California. J Clin Microbiol August 2005; 43(8): 4280–4282.CrossRefGoogle ScholarPubMed
Aureli, P, Fenicia, L, Pasolini, B, Gianfranceschi, M, McCroskey, LM, Hatheway, CL. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis August 1986; 154(2): 207–211.CrossRefGoogle ScholarPubMed
Passaro, DJ, Werner, SB, McGee, J, Mac Kenzie, WR, Vugia, DJ. Wound botulism associated with black tar heroin among injecting drug users. JAMA March 18, 1998; 279(11): 859–863.CrossRefGoogle ScholarPubMed
Spika, JS, Shaffer, N, Hargrett-Bean, N, Collin, S, MacDonald, KL, Blake, PA. Risk factors for infant botulism in the United States. Am J Dis Child July 1989; 143(7): 828–832.Google ScholarPubMed
Arnon, SS, Schechter, R, Maslanka, SE, Jewell, NP, Hatheway, CL. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med February 2, 2006; 354(5): 462–471.CrossRefGoogle ScholarPubMed
Borio, L, Inglesby, T, Peters, CJ, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002; 287: 2391–2405.CrossRefGoogle ScholarPubMed
Snell, NJ. Ribavirin–current status of a broad spectrum antiviral agent. Expert Opin Pharmacother 2001; 2: 1317–1324.CrossRefGoogle ScholarPubMed
Rusnak, JM H., Byrne, WR, Chung, KN, et al. Experience with ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res January 2009; 81(1): 68–76.CrossRefGoogle ScholarPubMed
Mertz, GJ, Miedzinski, L, Goade, D, et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004; 39: 1307–1313.CrossRefGoogle ScholarPubMed
Gowen, BB, Bray, M. Progress in the experimental therapy of severe arenaviral infections. Future Microbiol December 2011; 6(12): 1429–1441.CrossRefGoogle ScholarPubMed
McCormick, JB, King, I, Webb, P, et al. Lassa fever: Effective therapy with Ribavirin. N Engl J Med 1986; 314: 20–26.CrossRefGoogle ScholarPubMed
Cetron, MS, Marfin, AA, Julian, KG, et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2002; 51(RR-17): 1–11.Google ScholarPubMed
Dennis, DT, Inglesby, TV, Henderson, DA, et al. Tularemia as a biological weapon, medical and public health management. JAMA 2001; 285: 2763–2773.CrossRefGoogle ScholarPubMed
Rogozin, II. Tularemia prevention during the Second World War. Zh Mikrobiol Epidemiol Immunobiol 1970; 47: 23–26.Google ScholarPubMed
Croddy, E, Krcalova, S. Tularemia, biological warfare, and the battle for Stalingrad (1942–1943). Mil Med 2001; 166: 837–838.CrossRefGoogle ScholarPubMed
Alibek, K. Biohazard. New York, Random House, 1999; 29–38.Google Scholar
Feldman, KA, Enscore, RE, Lathrop, SL, et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. New Engl J Med 2001; 345: 1601–1606.CrossRefGoogle ScholarPubMed
Feldman, KA, Stiles-Enos, D, Julian, K, et al. Tularemia on Martha's Vineyard: Seroprevalence and occupational risk. Emerg Infect Dis 2003; 9: 350–354.CrossRefGoogle ScholarPubMed
Rusnak, JM, Kortepeter, MG, Hawley, RJ, et al. Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers. Biosecur Bioterror 2004; 2: 281–293.CrossRefGoogle ScholarPubMed
Enderlin, G, Morales, L, Jacobs, RF, Cross, JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994; 19: 42–47.CrossRefGoogle ScholarPubMed
Marohn, ME, Barry, EM. Live attenuated tularemia vaccines: Recent developments and future goals. Vaccine 2013; 31: 3485–3491.CrossRefGoogle ScholarPubMed
4th July, 1817, 42d year. [Bennington]. Vermont Gazette. July 8, 1817; 2: “let your motto be ‘eternal vigilance is the price we pay for liberty.’”Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×